Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JYHB2200568 | 利伐沙班干混悬剂 | rivaroxaban | Suspension | Chemical Drugs(2.2) | Supplementary Application | 2022-10-20 | Bayer AG | view | |||
JYHB2200567 | 利伐沙班干混悬剂 | rivaroxaban | Suspension | Chemical Drugs(2.2) | Supplementary Application | 2022-10-20 | Bayer AG | view | |||
CYHS2401485 | 利伐沙班干混悬剂 | rivaroxaban | Suspension | Chemical Drugs(4) | Generic Drug | 2024-05-17 | Nanjing Healthnice Pharmaceutical Co Ltd | view | |||
CYHS2401486 | 利伐沙班干混悬剂 | rivaroxaban | Suspension | Chemical Drugs(4) | Generic Drug | 2024-05-17 | Nanjing Healthnice Pharmaceutical Co Ltd | view |